glp-1 psychiatry Usage Does Not Increased Risk of Psychiatric Events, Study Finds GLP-1 Receptor Agonists in Mood

Here, we demonstrate that the effects of cotadutide in reducing body weight and food intake and improving glucose control are predominantly mediated through Glp-1 signalling, whereas its action on the liver to reduce lipid content, drive glycogen flux and improve mitochondrial turnover and function are directly mediated through Gcg signalling

doi:10.2337/dc21-1785 Baggio LL, Yusta B, Mulvihill EE, et al

(9) Christensen, S., et al

While the ADJUNCT TWO also reported an increased rate ratio of symptomatic hypoglycemia of 1.33 on 1.2 mg liraglutide, events were not significantly different with the 1.8 mg dose in that study

Novo Nordisk would not comment on the new pharmacy benefits arrangements